| Literature DB >> 29931387 |
C Zeidler1, M Metz2, S Steinke3, S Ständer3.
Abstract
Chronic pruritus is one of the most common and stressful symptoms in medicine. Therapy remains a great challenge because of the lack of approved therapies. In the recent past a greater understanding of the pathogenesis has enabled the results to be translated into new forms of therapy. The various therapies target a wide range of points in the pruritic cascade-from blockade of intracellular and intercellular signaling pathways in the skin to the modulation of neurotransmission. This article provides a summary of current therapeutic options based on the current S2K guideline and gives an overview about recent developments in antipruritic treatments.Entities:
Keywords: Biologics; Itch; Neurotransmission; Quality of life; Signal pathways
Mesh:
Substances:
Year: 2018 PMID: 29931387 DOI: 10.1007/s00105-018-4221-7
Source DB: PubMed Journal: Hautarzt ISSN: 0017-8470 Impact factor: 0.751